Lercanidipine
- OralLercanidipineZanidip
Mechanism of Action
- Inhibits L-type calcium channels on ventricular myocardial, cardiac nodal and arteriolar smooth muscle cells.
Pharmacology
- Selectively inhibits calcium channels on arteriolar smooth muscle cells, resulting in significant vasodilation without cardiodepression.
Clinical Use
Indications
- Hypertension - first line treatment
Contraindications
- Heart failure.
- Adverse Effects
- Fatigue
- Oedema
- Dizziness
- Headache
- Nausea / abdo pain